C Fenwick, P Turelli, C Pellaton, A Farina… - Science Translational …, 2021 - science.org
The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific antibodies in the serum of an individual indicates previous infection or vaccination …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are concerning in the ongoing coronavirus disease 2019 (COVID-19) pandemic. Here, we developed a rapid …
KR Rus, M Korva, N Knap, TA Županc… - Journal of Clinical …, 2021 - Elsevier
Background Neutralization tests (NT) are the gold standard for detecting and quantifying anti- SARS-CoV-2 neutralizing antibodies (NAb), but their complexity restricts them to research …
In order to support vaccine development, and to aid convalescent plasma therapy, it would be important to understand the kinetics, timing and persistence of SARS-CoV-2 neutralizing …
A Valdivia, I Torres, V Latorre… - European Journal of …, 2021 - Springer
Whether antibody levels measured by commercially available enzyme or chemiluminescent immunoassays targeting the SARS-CoV-2 spike (S) protein can act as a proxy for serum …
Antibody-based interventions against SARS-CoV-2 could limit morbidity, mortality, and possibly transmission. An anticipated correlate of such countermeasures is the level of …
Determinants of protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection require the development of well-standardized, reproducible …
E Salazar, SV Kuchipudi… - The Journal of …, 2020 - Am Soc Clin Investig
The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) highlights the urgent need for assays that detect protective levels of neutralizing antibodies …
T Xiang, B Liang, Y Fang, S Lu, S Li, H Wang… - Frontiers in …, 2021 - frontiersin.org
Major advances have been made in understanding the dynamics of humoral immunity briefly after the acute coronavirus disease 2019 (COVID-19). However, knowledge …